A Multicenter Open-Label Extension Study To Assess Long-Term Safety Of PF-00547659 In Subjects With Ulcerative Colitis (TURANDOT II)
Phase of Trial: Phase II
Latest Information Update: 20 Apr 2018
At a glance
- Drugs SHP 647 (Primary)
- Indications Ulcerative colitis
- Focus Adverse reactions
- Acronyms TURANDOT-II
- Sponsors Pfizer; Shire
- 21 Dec 2017 Status changed from active, no longer recruiting to completed.
- 01 Feb 2017 This trial has been completed in Bulgaria as per European Clinical Trials Database record.
- 26 Dec 2016 This trial has been completed in Bulgaria as per European Clinical Trials Database record.